Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 56 min ago
Peer-reviewedLicence not statedLancet (London, England)

Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9–23 months in Uganda: a phase 4, single-blind, randomised clinical trial

13 more authors

Related

  1. Therapeutic Equivalence, Immunogenicity, and Safety of Euvichol Oral Cholera Vaccine Formulations Compared with WHO-prequalified Shanchol vaccine in Healthy Children and Adults: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
    K. M. Al-Dhayani, Z. A. Hasan, K. B. A. Alastah +2
    bioRxivPreprintCC BYFull textPharmacology & toxicologybioRxiv
  2. Lesion sterilisation and tissue repair with chloramphenicol, tetracycline, zinc oxide-eugenol paste compared to zinc oxide-eugenol pulpectomy in primary molars: Two-year follow-up findings of a multicentre non-inferiority randomised clinical trial
    P. S. Santos, T. Ramos, G. d. C. Fernandes +10
    medRxivPreprintCC BY-NC-NDFull textGeneral medicinemedRxiv
  3. Methotrexate and Prednisolone compared to placebo and prednisolone in the treatment of severe Erythema Nodosum Leprosum: An international multicentre, double-blind randomised controlled clinical trial—MaPs in ENL
    Barbara de Barros, Farha Sultana, Neeta Maximus +19
    PLOS Neglected Tropical DiseasesPeer-reviewedCC BY 4.0Full textImmunologyInfectious diseasePLOS
  4. Immunogenicity and safety of Sabin inactivated poliovirus vaccine in a sequential schedule with bivalent oral poliovirus vaccine in Nepal: a single-centre, double-blind, randomised, controlled, non-inferiority trial
    Arun K Sharma, Visalakshi Jeyaseelan, Sudha Basnet +8
    The Lancet Global HealthPeer-reviewedCC BY 4.0Epidemiology & public healthCrossref
  5. A randomised, double-blind, multicentre, placebo-controlled phase 3 efficacy, safety, and immunogenicity study of an Ad26.RSV.preF/RSV prefusion F-protein vaccine for the prevention of respiratory syncytial virus-mediated lower respiratory tract disease in adults aged 60 years and older
    Christy A. Comeaux, Marco Testa, Efi Gymnopoulou +15
    eBioMedicinePeer-reviewedCC BY 4.0General medicineCrossref
BibTeX
@article{doshi2026immunogenicity,
  title = {{Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9–23 months in Uganda: a phase 4, single-blind, randomised clinical trial}},
  author = {Reena H Doshi and Irene Lubega and Pierre Muhoza and Grace Carlock and Arthur Brian Sekiziyivu and Alexandra Tuttle and Marjorie Najjengo and John Kayiwa and Rebecca Casey and Eric C Mossel and Winfred Nakato and Conrad Tumwine and Ellon Twinomuhwezi and Julius Lutwama and Annet Nankya and Leonara Rebecca Nabatanzi and Semakula Charles and Allison M Brown and Jennifer Harris and Leora Feldstein and Susan Chu and Hongjiang Gao and Andrew Kambugu and J Erin Staples and Terri B Hyde},
  journal = {Lancet (London, England)},
  year = {2026},
  month = sep,
  doi = {10.1016/s0140-6736(26)01390-5},
  url = {https://doi.org/10.1016/s0140-6736(26)01390-5},
}
RIS
TY  - JOUR
TI  - Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9–23 months in Uganda: a phase 4, single-blind, randomised clinical trial
AU  - Reena H Doshi
AU  - Irene Lubega
AU  - Pierre Muhoza
AU  - Grace Carlock
AU  - Arthur Brian Sekiziyivu
AU  - Alexandra Tuttle
AU  - Marjorie Najjengo
AU  - John Kayiwa
AU  - Rebecca Casey
AU  - Eric C Mossel
AU  - Winfred Nakato
AU  - Conrad Tumwine
AU  - Ellon Twinomuhwezi
AU  - Julius Lutwama
AU  - Annet Nankya
AU  - Leonara Rebecca Nabatanzi
AU  - Semakula Charles
AU  - Allison M Brown
AU  - Jennifer Harris
AU  - Leora Feldstein
AU  - Susan Chu
AU  - Hongjiang Gao
AU  - Andrew Kambugu
AU  - J Erin Staples
AU  - Terri B Hyde
PY  - 2026
DA  - 2026/09/11
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(26)01390-5
UR  - https://doi.org/10.1016/s0140-6736(26)01390-5
SN  - 0140-6736
SN  - 1474-547X
ER  -